ADIPOQ and Insulin resistance: In addition, the studies have shown that adiponectin treatment enhances insulin-stimulated glucose phagocytosis by activating AMPK in primary adipocytes of rats, which has the potential to improve insulin resistance and type II diabetes [47,48].